Your Privacy Is Protected
Your name and information will not be shared with any third party for any reason.
If you're an adult between 18 and 70 who has been taking a GLP-1 medication for at least 6 months and your weight loss has plateaued, you may be eligible for an upcoming clinical research study. This study is evaluating an investigational injectable treatment given under the skin of the abdomen, in addition to your ongoing weight-loss medication, to reduce stubborn abdominal fat in people who are overweight or obese.
Participation lasts about 12 months and includes six treatment visits roughly 4 weeks apart, plus periodic follow-up visits.
If you'd be interested in participating in a study like this one, simply fill out the questionnaire below and qualified participants will be contacted if research opportunities become available. Your name and information will not be shared with any third party for any reason.
Your responses help researchers develop trials with patients in mind.
All responses are confidential. Let’s see if a study might be a fit.
Your name and information will not be shared with any third party for any reason.
Answer a few simple questions to see if you may be eligible. Qualified participants will be contacted if opportunities are available.
Qualify and we’ll reach out when a research opportunity becomes available near you.
Your information is confidential and will not be shared with third parties.